Sarcopenia as a risk factor of severe laboratory adverse events in breast cancer patients receiving perioperative epirubicin plus cyclophosphamide therapy - Concepedia

Concepedia

Publication | Closed Access

Sarcopenia as a risk factor of severe laboratory adverse events in breast cancer patients receiving perioperative epirubicin plus cyclophosphamide therapy

25

Citations

22

References

2020

Year

Ayako Ueno, Kazushige Yamaguchi, Moe Sudo, Shiro Imai

Supportive Care in Cancer

Breast Cancer PatientsMedicineMetronomic TherapyCyclophosphamide TherapyBreast CancerPharmacotherapySurgeryCancer TreatmentOncologyPerioperative Epirubicin

References

	Year	Citations

Page 1